These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 19181301

  • 1. Extensive macular atrophy with pseudodrusen-like appearance: a new clinical entity.
    Hamel CP, Meunier I, Arndt C, Ben Salah S, Lopez S, Bazalgette C, Bazalgette C, Zanlonghi X, Arnaud B, Defoort-Dellhemmes S, Puech B.
    Am J Ophthalmol; 2009 Apr; 147(4):609-20. PubMed ID: 19181301
    [Abstract] [Full Text] [Related]

  • 2. Extensive macular atrophy with pseudodrusen-like appearance: a new clinical entity.
    Boon CJ, Theelen T, Hoyng CB.
    Am J Ophthalmol; 2009 Jul; 148(1):173-4; author reply 174-5. PubMed ID: 19540988
    [No Abstract] [Full Text] [Related]

  • 3. Extensive Macular Atrophy with Pseudodrusen-like appearance: Progression Kinetics and Late-Stage Findings.
    Antropoli A, Bianco L, Condroyer C, Antonio A, Navarro J, Dagostinoz D, Benadji A, Sahel JA, Zeitz C, Audo I.
    Ophthalmology; 2024 Oct; 131(10):1175-1184. PubMed ID: 38583493
    [Abstract] [Full Text] [Related]

  • 4. Persistent placoid maculopathy: a new clinical entity.
    Golchet PR, Jampol LM, Wilson D, Yannuzzi LA, Ober M, Stroh E.
    Ophthalmology; 2007 Aug; 114(8):1530-40. PubMed ID: 17678692
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of Stargardt's disease and fundus flavimaculatus.
    Armstrong JD, Meyer D, Xu S, Elfervig JL.
    Ophthalmology; 1998 Mar; 105(3):448-57; discussion 457-8. PubMed ID: 9499775
    [Abstract] [Full Text] [Related]

  • 6. Extensive macular atrophy with pseudodrusen-like appearance: comprehensive review of the literature.
    Carlà MM, Giannuzzi F, Boselli F, Crincoli E, Rizzo S.
    Graefes Arch Clin Exp Ophthalmol; 2024 Oct; 262(10):3085-3097. PubMed ID: 39133226
    [Abstract] [Full Text] [Related]

  • 7. Extensive macular atrophy with pseudodrusen-like appearance.
    Querques G, Blanco R, Puche N, Massamba N, Souied EH.
    Ophthalmology; 2013 Feb; 120(2):429.e1-2. PubMed ID: 23374569
    [No Abstract] [Full Text] [Related]

  • 8. A reappraisal of the clinical spectrum of North Carolina macular dystrophy.
    Khurana RN, Sun X, Pearson E, Yang Z, Harmon J, Goldberg MF, Zhang K.
    Ophthalmology; 2009 Oct; 116(10):1976-83. PubMed ID: 19616854
    [Abstract] [Full Text] [Related]

  • 9. A comparison of macular translocation with patch graft in neovascular age-related macular degeneration.
    Chen FK, Patel PJ, Uppal GS, Rubin GS, Coffey PJ, Aylward GW, Da Cruz L.
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1848-55. PubMed ID: 19060287
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction.
    Michaelides M, Jenkins SA, Brantley MA, Andrews RM, Waseem N, Luong V, Gregory-Evans K, Bhattacharya SS, Fitzke FW, Webster AR.
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3085-97. PubMed ID: 16799055
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical Characteristics and Risk Factors of Extensive Macular Atrophy with Pseudodrusen: The EMAP Case-Control National Clinical Trial.
    Douillard A, Picot MC, Delcourt C, Lacroux A, Zanlonghi X, Puech B, Defoort-Dhelemmes S, Drumare I, Jozefowicz E, Bocquet B, Baudoin C, Al-Dain Marzouka N, Perez-Roustit S, Arsène S, Gissot V, Devin F, Arndt C, Wolff B, Mauget-Faÿsse M, Quaranta M, Mura T, Deplanque D, Oubraham H, Cohen SY, Gastaud P, Zambrowsky O, Creuzot-Garcher C, Mohand Saïd S, Blanco Garavito R, Souied E, Sahel JA, Audo I, Hamel C, Meunier I.
    Ophthalmology; 2016 Sep; 123(9):1865-73. PubMed ID: 27320518
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Late onset is common in best macular dystrophy associated with VMD2 gene mutations.
    Renner AB, Tillack H, Kraus H, Krämer F, Mohr N, Weber BH, Foerster MH, Kellner U.
    Ophthalmology; 2005 Apr; 112(4):586-92. PubMed ID: 15808248
    [Abstract] [Full Text] [Related]

  • 16. [Complex diagnosis of the early macular changes due to AMD].
    Kwiecień S, Szaflik JP, Szaflik J.
    Klin Oczna; 2007 Apr; 109(4-6):209-13. PubMed ID: 17725289
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of reticular pseudodrusen on macular function.
    Querques G, Massamba N, Srour M, Boulanger E, Georges A, Souied EH.
    Retina; 2014 Feb; 34(2):321-9. PubMed ID: 23842105
    [Abstract] [Full Text] [Related]

  • 19. Choroidal neovascularization associated with extensive macular atrophy with pseudodrusen-like appearance.
    Kamami-Levy C, Querques G, Rostaqui O, Blanco-Garavito R, Souied EH.
    J Fr Ophtalmol; 2014 Dec; 37(10):780-6. PubMed ID: 25278483
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.